查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930108

全球蛋白质体学市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Proteomics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 151 Pages | 商品交期: 请询问到货日

价格

蛋白质体学市场成长驱动因素

受生命科学研究投资增加、个人化医疗需求成长以及蛋白质分析技术快速发展的推动，全球蛋白质体学市场正经历强劲且持续的成长。根据 Fortune Business Insights 的数据显示，2025 年蛋白质体学市场规模为 419.7 亿美元，预计 2026 年将达到 469.7 亿美元，2034 年将达到 1,256.4 亿美元，预测期内复合年增长率 (CAGR) 为 13.09%。北美地区在 2025 年占市场主导地位，市占率达 43.75%。这得归功于其强大的研发基础设施和先进蛋白质体学技术的高普及率。

蛋白质体学是指对在生物体的结构、功能和调控中发挥关键作用的蛋白质进行大规模研究。蛋白质组代表细胞、组织或生物体表达的所有蛋白质的集合，对其进行分析对于理解疾病机制、识别生物标记和支持药物研发至关重要。

市场动态

全球对蛋白质体学研究的浓厚兴趣是推动该市场发展的主要因素。研究人员正日益深入地探索人类蛋白质组，以识别疾病生物标记、分析蛋白质相互作用并发现新的药物标靶。精准医疗和个人化医疗的日益普及进一步加速了蛋白质体学的应用，因为蛋白质水平的洞察能够帮助临床医生预测患者对特定疗法的反应并制定标靶治疗策略。

此外，不断增长的公共和私人投资也推动了蛋白质体学平台和工作流程的创新。 例如，Syncell 于 2024 年 12 月获得 1,500 万美元 A 轮融资，用于拓展其太空蛋白质体学和蛋白质纯化技术的商业化应用，这表明投资者对该领域的信心日益增强。

然而，市场面临一些技术限制，在一定程度上限制了成长。蛋白质组高度复杂且动态变化，蛋白质会经历各种翻译后修饰，并以多种亚型存在。检测和定量高丰度和低丰度蛋白质仍然具有挑战性，需要先进的仪器和复杂的数据分析演算法。这种复杂性增加了成本，并限制了大样本研究的可扩展性。

机会与挑战

个人化医疗的兴起为蛋白质体学市场带来了巨大的成长机会。透过分析个别蛋白质谱，蛋白质体学能够开发个人化疗法，改善疾病预后，并提高治疗效果。 预计这一趋势将推动製药和生技公司进一步投资。

同时，资料复杂性构成了一项重大挑战。蛋白质体学产生大量且复杂的资料集，其解读需要先进的计算工具。将蛋白质组学数据与基因组学和转录组学数据整合对于获得全面的生物学见解至关重要，但这种整合在技术上具有挑战性，且需要大量资源。

市场趋势

技术进步是塑造蛋白质体学市场的关键趋势。质谱技术的创新、通量的提高、灵敏度的增强以及单细胞蛋白质体学的出现正在拓展其应用领域。 2025年6月，赛默飞世尔科技在ASMS大会上发表了先进的质谱解决方案，再次强调了创新对于推动市场成长的重要性。

细分市场分析

依产品类型划分，产品占市场主导地位，预计到 2026 年将保持 55.42% 的市场占有率，这主要得益于研发领域对设备和耗材的广泛应用。同时，由于对生物资讯学和外包蛋白质组学分析的需求不断增长，服务预计将保持稳定成长。

依技术类型划分，质谱技术预计将引领市场，到 2026 年将占 35.55% 的市场占有率，这主要得益于其在药物发现、生物标记鑑定和临床研究中的广泛应用。

依应用领域划分，药物发现预计将在 2024 年占市场首位，这主要得益于研发活动的增加和对标靶治疗需求的增长。 依最终用户划分，预计到 2026 年，製药和生物技术公司将占市场主导地位，市场占有率高达 69.56%，这反映了蛋白质组学在治疗药物开发中的广泛应用。

区域展望

预计到 2025 年，北美市场规模将达到 183.6 亿美元，主要得益于强劲的投资、先进的技术以及对个人化医疗的重视。美国仍将是最大的贡献者，到 2026 年市场规模将达到 187.6 亿美元。欧洲市场由于研发举措的支持而保持稳步增长，而亚太地区预计将实现最快增长，这得益于政府资金投入、基础设施建设以及中国、印度和日本等国家日益增长的应用。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 蛋白质体学技术进展
  • 主要国家和地区的监管状况
  • 关键产业趋势：併购、业务合作等
  • 主要公司的新产品发布

第五章 全球蛋白质体学市场分析：洞察与预测 （2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 产品
      • 仪器
      • 耗材
    • 服务
      • 生物资讯学
      • 核心服务
  • 市场分析、洞察与预测：依技术划分
    • 质谱分析
    • 色谱分析
    • 电泳分析
    • X射线晶体绕射分析
    • 蛋白质显微镜阵列分析
    • 其他
  • 市场分析、洞察与预测：依应用领域划分
    • 药物发现
    • 临床诊断
    • 其他
  • 市场分析、洞察与预测：以最终用户划分用户
    • 製药和生技公司
    • 研究和学术机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美蛋白质体学市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲蛋白质体学市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区蛋白质体学市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲蛋白质体学市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美国

第十章：中东与非洲蛋白质体学市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • Agilent Technologies Inc.
    • Thermo Fisher Scientific Inc.
    • Bio Rad Laboratories Inc.
    • Illumina Inc.
    • QIAGEN
    • Shimadzu Corporation
    • Promega Corporation
    • Danaher
    • Waters Corporation
    • Bruker
Product Code: FBI106940

Growth Factors of proteomics Market

The global proteomics market is experiencing strong and sustained growth, driven by rising investments in life science research, increasing demand for personalized medicine, and rapid technological advancements in protein analysis. According to Fortune Business Insights, the proteomics market was valued at USD 41.97 billion in 2025. The market is projected to be worth USD 46.97 billion in 2026 and is expected to reach USD 125.64 billion by 2034, growing at a CAGR of 13.09% during the forecast period. In 2025, North America dominated the market with a share of 43.75%, supported by strong R&D infrastructure and high adoption of advanced proteomics technologies.

Proteomics refers to the large-scale study of proteins, which play a critical role in the structure, function, and regulation of living organisms. The proteome represents the complete set of proteins expressed by a cell, tissue, or organism, and its analysis is essential for understanding disease mechanisms, identifying biomarkers, and supporting drug discovery efforts.

Market Dynamics

The market is primarily driven by the strong global focus on proteomics research. Researchers are increasingly studying the human proteome to identify disease biomarkers, analyze protein interactions, and discover novel drug targets. The growing emphasis on precision and personalized medicine further accelerates the adoption of proteomics, as protein-level insights allow clinicians to predict patient responses to specific therapies and design targeted treatment strategies.

In addition, rising public and private investments are supporting innovation in proteomics platforms and workflows. For example, in December 2024, Syncell secured USD 15 million in Series A funding to expand commercialization of its spatial proteomics and protein purification technologies, highlighting increasing investor confidence in this field.

However, the market faces technical limitations that restrain growth to some extent. The proteome is highly complex and dynamic, with proteins undergoing various post-translational modifications and existing in multiple isoforms. Detecting and quantifying both high- and low-abundance proteins remains challenging, requiring advanced instruments and sophisticated data analysis algorithms. These complexities increase costs and limit scalability for large sample studies.

Opportunities and Challenges

The shifting focus toward personalized medicine presents a major growth opportunity for the proteomics market. By analyzing individual protein profiles, proteomics enables the development of tailored therapies, improved disease prognosis, and better treatment outcomes. This trend is expected to drive further investments from pharmaceutical and biotechnology companies.

At the same time, data complexity poses a significant challenge. Proteomics generates large and complex datasets that require advanced computational tools for interpretation. Integrating proteomics data with genomics and transcriptomics is essential for comprehensive biological insights, but this integration is technically demanding and resource-intensive.

Market Trends

Technological advancements are a key trend shaping the proteomics market. Innovations in mass spectrometry, increased throughput, enhanced sensitivity, and the emergence of single-cell proteomics are expanding application areas. In June 2025, Thermo Fisher Scientific introduced advanced mass spectrometry solutions at the ASMS Conference, reinforcing the importance of innovation in driving market growth.

Segmentation Insights

By offering, products dominate the market and are projected to hold a 55.42% share in 2026, driven by widespread adoption of instruments and consumables in R&D. Services are expected to grow steadily due to rising demand for bioinformatics and outsourced proteomics analysis.

By technology, mass spectrometry leads the market with a projected 35.55% share in 2026, owing to its extensive use in drug discovery, biomarker identification, and clinical research.

In terms of application, drug discovery held the leading position in 2024, supported by increasing R&D activities and demand for targeted therapies. By end user, pharmaceutical and biotechnology companies dominated the market with a 69.56% share in 2026, reflecting heavy utilization of proteomics in therapeutic development.

Regional Outlook

In 2025, North America generated USD 18.36 billion, driven by strong investments, advanced technologies, and a focus on personalized medicine. The U.S. remains the largest contributor and is expected to reach USD 18.76 billion by 2026. Europe is showing steady growth due to supportive research initiatives, while Asia Pacific is expected to witness the fastest growth, supported by government funding, infrastructure development, and rising adoption in countries such as China, India, and Japan.

Conclusion

The global proteomics market is set for significant expansion, growing from USD 41.97 billion in 2025 to USD 125.64 billion by 2034. Strong research focus, technological advancements, and increasing adoption in personalized medicine and drug discovery are driving this growth. Although technical and data-related challenges persist, continuous innovation and rising investments are expected to strengthen the market outlook, making proteomics a cornerstone technology in modern life sciences and healthcare.

Segmentation By Offering

  • Products
    • Instruments
    • Consumables
  • Services
    • Bioinformatics
    • Core Services

By Technology

  • Mass Spectrometry
  • Chromatography
  • Electrophoresis
  • X-Ray Crystallography
  • Protein Microarray
  • Others

By Application

  • Drug Discovery
  • Clinical Diagnostics
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Others

By Region

  • North America (By Offering, Technology, Application, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Technology, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Technology, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Technology, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Technology, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Proteomics
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players

5. Global Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
      • 5.1.1.2. Consumables
    • 5.1.2. Services
      • 5.1.2.1. Bioinformatics
      • 5.1.2.2. Core Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Mass Spectrometry
    • 5.2.2. Chromatography
    • 5.2.3. Electrophoresis
    • 5.2.4. X-Ray Crystallography
    • 5.2.5. Protein Microarray
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Drug Discovery
    • 5.3.2. Clinical Diagnostics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. Research & Academic Institutes
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
      • 6.1.1.2. Consumables
    • 6.1.2. Services
      • 6.1.2.1. Bioinformatics
      • 6.1.2.2. Core Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Mass Spectrometry
    • 6.2.2. Chromatography
    • 6.2.3. Electrophoresis
    • 6.2.4. X-Ray Crystallography
    • 6.2.5. Protein Microarray
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Drug Discovery
    • 6.3.2. Clinical Diagnostics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. Research & Academic Institutes
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
      • 7.1.1.2. Consumables
    • 7.1.2. Services
      • 7.1.2.1. Bioinformatics
      • 7.1.2.2. Core Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Mass Spectrometry
    • 7.2.2. Chromatography
    • 7.2.3. Electrophoresis
    • 7.2.4. X-Ray Crystallography
    • 7.2.5. Protein Microarray
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Drug Discovery
    • 7.3.2. Clinical Diagnostics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Research & Academic Institutes
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
      • 8.1.1.2. Consumables
    • 8.1.2. Services
      • 8.1.2.1. Bioinformatics
      • 8.1.2.2. Core Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Mass Spectrometry
    • 8.2.2. Chromatography
    • 8.2.3. Electrophoresis
    • 8.2.4. X-Ray Crystallography
    • 8.2.5. Protein Microarray
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Drug Discovery
    • 8.3.2. Clinical Diagnostics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Research & Academic Institutes
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
      • 9.1.1.2. Consumables
    • 9.1.2. Services
      • 9.1.2.1. Bioinformatics
      • 9.1.2.2. Core Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Mass Spectrometry
    • 9.2.2. Chromatography
    • 9.2.3. Electrophoresis
    • 9.2.4. X-Ray Crystallography
    • 9.2.5. Protein Microarray
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Drug Discovery
    • 9.3.2. Clinical Diagnostics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Research & Academic Institutes
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Proteomics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
      • 10.1.1.2. Consumables
    • 10.1.2. Services
      • 10.1.2.1. Bioinformatics
      • 10.1.2.2. Core Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Mass Spectrometry
    • 10.2.2. Chromatography
    • 10.2.3. Electrophoresis
    • 10.2.4. X-Ray Crystallography
    • 10.2.5. Protein Microarray
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Drug Discovery
    • 10.3.2. Clinical Diagnostics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. Research & Academic Institutes
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Agilent Technologies Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Bio Rad Laboratories Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Illumina Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. QIAGEN
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Shimadzu Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Promega Corporation
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Danaher
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Waters Corporation
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Bruker
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 2: Global Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 3: Global Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 4: Global Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 5: Global Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 6: Global Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Proteomics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 9: North America Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 10: North America Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 11: North America Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 12: North America Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: North America Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Proteomics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 16: Europe Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 17: Europe Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 18: Europe Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 19: Europe Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Europe Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 23: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 24: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 25: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 26: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 30: Latin America Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 31: Latin America Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 32: Latin America Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 33: Latin America Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Latin America Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 37: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Products, 2021-2034
  • Table 38: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Services, 2021-2034
  • Table 39: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 40: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Proteomics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Proteomics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Proteomics Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Proteomics Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Proteomics Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Proteomics Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Proteomics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 8: North America Proteomics Market Value Share (%), By Offering, 2025
  • Figure 9: North America Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America Proteomics Market Value Share (%), by Technology, 2025
  • Figure 11: North America Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America Proteomics Market Value Share (%), By Application, 2025
  • Figure 13: North America Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Proteomics Market Value Share (%), by End User, 2025
  • Figure 15: North America Proteomics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Proteomics Market Value Share (%), By Country, 2025
  • Figure 17: Europe Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 18: Europe Proteomics Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe Proteomics Market Value Share (%), by Technology, 2025
  • Figure 21: Europe Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe Proteomics Market Value Share (%), By Application, 2025
  • Figure 23: Europe Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Proteomics Market Value Share (%), by End User, 2025
  • Figure 25: Europe Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Proteomics Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific Proteomics Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Proteomics Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Proteomics Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 38: Latin America Proteomics Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Latin America Proteomics Market Value Share (%), by Technology, 2025
  • Figure 41: Latin America Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Latin America Proteomics Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Proteomics Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Proteomics Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Proteomics Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Proteomics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 50: Middle East & Africa Proteomics Market Value Share (%), by Technology, 2025
  • Figure 51: Middle East & Africa Proteomics Market Value (USD billion), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Proteomics Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Proteomics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Proteomics Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Proteomics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Proteomics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Proteomics Market Share (%), By Company, 2025